{"id":90007,"date":"2026-11-08T00:12:18","date_gmt":"2026-11-08T00:12:18","guid":{"rendered":"https:\/\/wallstreetresearch.org\/wsr\/?p=90007"},"modified":"2026-11-08T00:12:18","modified_gmt":"2026-11-08T00:12:18","slug":"diabetes-reversal-group-corporate-report-2022","status":"publish","type":"wsr_report","link":"https:\/\/wallstreetresearch.org\/wsr\/research\/diabetes-reversal-group-corporate-report-2022\/","title":{"rendered":"Diabetes Reversal Group, LLC: Corporate Report"},"content":{"rendered":"<p>Diabetes Reversal Group LLC (DRG), based in Dallas, Texas, provides telemedicine services focused on the complete reversal of Type 2 diabetes through patented, individualized natural therapy programs. Its method combines specific diet and exercise regimens, proprietary nutritional supplements, comprehensive lab analysis and personal physician support, with the aim of letting patients stop blood-sugar-lowering drugs such as insulin and metformin and become clinically non-diabetic within two to six months. The DRG method was granted U.S. patent number 10,765,318 in September 2020.<\/p>\n<p>DRG was founded in 2009 by Dr. J. Murray Hockings. According to the report, it has treated more than ten thousand patients in six countries and generated over $30 million in revenue through more than 400 seminars and 17 U.S. clinics before the COVID-19 lockdowns. Having permanently closed its clinics, DRG was building its revenue on a digital telehealth model using the telemedicine platform it introduced in April 2020.<\/p>\n<p>Private company \u00b7 Telemedicine<\/p>\n<p><a href=\"https:\/\/www.wallstreetresearch.org\/reports\/Diabetes-Reversal-Group.pdf\">Read the corporate report (PDF, 8 pages)<\/a><\/p>\n<p>Company website: <a href=\"https:\/\/diabetesreversalgroup.com\/\" target=\"_blank\" rel=\"noopener\">diabetesreversalgroup.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Based in Dallas, Texas, the company provides telemedicine services focused on a natural, drug free approach to reversing Type 2 diabetes.<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","meta":{"wsr_company":"Diabetes Reversal Group, LLC","wsr_report_label":"Corporate Report","wsr_report_kind":"profile","wsr_report_url":"https:\/\/www.wallstreetresearch.org\/reports\/Diabetes-Reversal-Group.pdf","wsr_report_pages":"8","wsr_report_date":"2022-12-29","wsr_report_undated":"","wsr_report_date_shown":"December 29, 2022","wsr_listing":"Private company","wsr_market":"private","wsr_symbol":"DRG","wsr_ticker":"","wsr_exchange":"Private","wsr_industry":"Telemedicine","wsr_website":"https:\/\/diabetesreversalgroup.com\/","wsr_milestone":"","wsr_logo":"l-drg.webp","wsr_cover_image":"cv-drg.webp","wsr_featured":"","wsr_in_cards":"1","wsr_track":"","wsr_track_priority":"","wsr_track_tile":"","wsr_track_only":"","footnotes":""},"tags":[78,56],"class_list":["post-90007","wsr_report","type-wsr_report","status-publish","hentry","tag-diabetes-reversal-group","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report"}],"about":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/types\/wsr_report"}],"author":[{"embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90007\/revisions"}],"predecessor-version":[{"id":97035,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90007\/revisions\/97035"}],"wp:attachment":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/media?parent=90007"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/tags?post=90007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}